Caterina Boldrin
Overview
Explore the profile of Caterina Boldrin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrarese A, Zanaga P, Battistella S, Zanella S, Zappitelli T, Boldrin C, et al.
Aliment Pharmacol Ther
. 2024 Dec;
61(4):667-674.
PMID: 39655800
Background: Screening programmes for the detection of patients with hepatitis C virus (HCV) and positive viral load have been developed in many countries to achieve the World Health Organization's goal...
2.
Lavezzo E, Pacenti M, Manuto L, Boldrin C, Cattai M, Grazioli M, et al.
Genome Med
. 2022 Jun;
14(1):61.
PMID: 35689243
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape properties, such as Delta (B.1.617.2) and Omicron (B.1.1.529), questions the extent of the antibody-mediated protection against the...
3.
Gittelman R, Lavezzo E, Snyder T, Jabran Zahid H, Carty C, Elyanow R, et al.
JCI Insight
. 2022 Apr;
7(10).
PMID: 35439174
T cells play a prominent role in orchestrating the immune response to viral diseases, but their role in the clinical presentation and subsequent immunity to SARS-CoV-2 infection remains poorly understood....
4.
Dorigatti I, Lavezzo E, Manuto L, Ciavarella C, Pacenti M, Boldrin C, et al.
Nat Commun
. 2021 Aug;
12(1):5020.
PMID: 34385465
No abstract available.
5.
Dorigatti I, Lavezzo E, Manuto L, Ciavarella C, Pacenti M, Boldrin C, et al.
Nat Commun
. 2021 Jul;
12(1):4383.
PMID: 34282139
In February and March 2020, two mass swab testing campaigns were conducted in Vo', Italy. In May 2020, we tested 86% of the Vo' population with three immuno-assays detecting antibodies...
6.
Salata C, Lisotto P, Boldrin C, De Canale E, Piccirillo A, Calistri A, et al.
New Microbiol
. 2018 Jul;
41(3):232-234.
PMID: 30028474
Listeriosis is a disease usually associated with the consumption of low-processed ready-to-eat food products contaminated by Listeria monocytogenes. In Italy, listeriosis has an incidence of 0.19-0.27 cases per 100000 persons....
7.
Andreis S, Basso M, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, et al.
J Glob Antimicrob Resist
. 2017 Jul;
10:106-112.
PMID: 28732792
Objectives: To characterize the prevalence of transmitted drug resistance mutations (TDRMs) by plasma analysis of 750 patients at the time of HIV diagnosis from January 1, 2013 to November 16,...
8.
Parisi S, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, et al.
J Glob Antimicrob Resist
. 2016 Nov;
1(4):201-206.
PMID: 27873613
The present study was designed to prospectively monitor transmitted drug resistance mutations (TDRMs) in the Veneto Region, Italy. Genotypic resistance testing was conducted on the plasma of 1882 patients consecutively...
9.
Parisi S, Andreis S, Mengoli C, Scaggiante R, Cruciani M, Ferretto R, et al.
BMC Infect Dis
. 2013 Jul;
13:314.
PMID: 23844927
Background: To determine if tropism for CXCR4 or CCR5 correlates with cellular HIV DNA load, residual viraemia and CD4 count in 219 successfully treated naive subjects with HIV infection enrolled...
10.
Parisi S, Andreis S, Mengoli C, Scaggiante R, Ferretto R, Manfrin V, et al.
J Clin Microbiol
. 2011 Dec;
50(2):258-63.
PMID: 22135262
Cellular human immunodeficiency virus type 1 (HIV-1) DNA may be considered a marker of disease progression with significant predictive power, but published data on its correlation with plasma HIV RNA...